The State of Patient Access 2025
Today, the access environment is more restrictive and interconnected than ever, prompting manufacturers to overhaul their timing, tactics and expectations. To understand this current state of affairs, MMIT and The Dedham Group conducted the second-annual State of Patient Access survey, in which a total of 250 pharma and biotech leaders across access, medical affairs and commercial strategy shared how payer restrictions are reshaping launch strategy. In this white paper, authors Izabela Chmielewska, Steve Callahan and Hannah Baxter share the key findings and what they mean for the future of patient access.
Download the Report
2025’s access environment is tighter, earlier and harder to navigate.
As such, manufacturers are prompted to overhaul their timing, tactics and expectations.
MMIT and The Dedham Group's annual state of the industry survey shows how pharma execs are responding to the evolving access landscape.